TherapeuticsMD (TXMD) Free Cash Flow (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly Free Cash Flow came in at $944000.0 in Q1 2026, up 35.05% YoY from $699000.0 in Q1 2025, and up 151.73% on a QoQ basis from $375000.0 in Q4 2025.
TherapeuticsMD (TXMD) Free Cash Flow (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 17 years of Free Cash Flow data on file, last reported at $944000.0 in Q1 2026.
- Quarterly Free Cash Flow rose 35.05% year-over-year to $944000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (up 28.65% YoY) and the FY2025 annual result came in at $2.5 million, up 109.74% from the prior year.
- Free Cash Flow improved to $944000.0 in Q1 2026, from $375000.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $22.6 million in Q4 2022 to a low of -$20.7 million in Q2 2022.
- A 5-year average of -$1.1 million and a median of $17000.0 in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2023 — Free Cash Flow tumbled 132.14% — and 2025, when it surged 2105.88%.
- Tracing TXMD's Free Cash Flow over 5 years: stood at $22.6 million in 2022, then plunged by 132.14% to -$7.3 million in 2023, then soared by 100.23% to $17000.0 in 2024, then surged by 2105.88% to $375000.0 in 2025, then jumped by 151.73% to $944000.0 in 2026.
- The last three Free Cash Flow figures came in at $944000.0 (Q1 2026), $375000.0 (Q4 2025), and $999000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | TherapeuticsMD | 23.78 Mn | 14.60 Mn | - | 779,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 779,000.00 |
| Jun 30, 2026 | 779,000.00 |
| Mar 31, 2026 | 944,000.00 |
| Mar 31, 2026 | 944,000.00 |
| Dec 31, 2025 | 375,000.00 |
| Dec 31, 2025 | 375,000.00 |
| Sep 30, 2025 | 999,000.00 |
| Sep 30, 2025 | 999,000.00 |
| Jun 30, 2025 | 381,000.00 |
| Jun 30, 2025 | 381,000.00 |
| Mar 31, 2025 | 699,000.00 |
| Mar 31, 2025 | 699,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | -71,000.00 |
| Sep 30, 2024 | -71,000.00 |
| Jun 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | -229,000.00 |
| Mar 31, 2024 | -229,000.00 |